期刊文献+

FAS-1377基因多态与胃癌风险

FAS-1377 POLYMORPHISMS AND RISK OF GASTRIC CANCER
下载PDF
导出
摘要 目的研究FAS-1377基因多态性与胃癌风险的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法,检测青海胃癌患者和正常人的FAS-1377基因多态性,用χ2检验分析其基因多态性与胃癌风险间的关系。结果胃癌组中FAS-1377基因多态分布为纯合野生型GG频率7.4%(7/95)、杂合型GA频率61.1%(58/95)、纯合突变型AA频率31.5%(30/95)。正常对照组中FAS-1377基因多态分布为纯合野生型GG频率41.1%(53/129)、杂合型GA频率34.1%(44/129)、纯合突变型AA频率24.8%(32/129)。FAS-1377基因多态与胃癌风险间存在关联(P<0.001)。结论 FAS-1377基因多态可能与胃癌风险有明显相关性。 Objective To investigate the correlation between FAS polymorphisms and the risk of gastric cancer.Methods The polymorphisms of FAS were detected by polymerase chain reaction-restriction fragment length polymorphisms assay(PCR-RFLP) in gastric cancer patients and in health people,χ2 was applied to assess the association between the polymorphisms of FAS and gastric cancer risk.Results In gastric cancer group,the frequency of FAS-1377 GG(homozygous wild type),GA(heterozygous type),AA(homozygous mutant type) was 7.4%(7/95),61.1%(58/95) and 31.5%(30/95) respectively.In the health control group,the frequency of FAS-1377GG,GA,AA was 41.1%(53/129),34.1%(44/129) and 24.8%(32/129) respectively.The polymorphisms of FAS-1377 gene may be associated with risk of gastric cancer(P〈0.001).Conclusion The polymorphisms of FAS-1377 gene may be associated with the risk of gastric cancer.
出处 《青海医学院学报》 CAS 2011年第1期13-15,24,共4页 Journal of Qinghai Medical College
基金 青海大学中青年科研基金项目(2008-QY-10)
关键词 FAS-1377 基因多态 胃癌 风险 FAS-1377 Gene polymorphisms Gastric cancer Risk
  • 相关文献

参考文献3

二级参考文献20

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2林东昕,孙瞳.单体型在肿瘤研究中的应用与展望[J].中华肿瘤杂志,2005,27(5):257-259. 被引量:5
  • 3李印,郑世营,葛锦峰,赵军,吴广州.贲门癌及癌前病变中细胞凋亡与FasL表达的关系[J].医药论坛杂志,2005,26(24):19-21. 被引量:1
  • 4Humlg QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol, 1997, 34:577-582.
  • 5Sibley K, Rollinson S, Allan JM, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res, 2003, 63:4327-4330.
  • 6Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancerbinding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. Immunol, 2003, 170 : 132-138.
  • 7Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 2004, 103:304- 309.
  • 8Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst, 2004, 96:1030-1036.
  • 9Ju ST, Panka DJ, Cui H, et al. Fas( CD95 )/Fas L interactions required for programmed cell death after T-cell activation. Nature, 1995, 373:444-448.
  • 10Krammer PH. CD95's deadly mission in the immune system. Nature, 2000, 407:789-795.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部